Fundraising Fox
Antwerp · Seed–Series B · 13 people tracked
Find your way into Heran Partners
Sign up to see every warm intro you have to Heran Partners
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Heran Partners team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Heran Partners backs enabling technologies in healthcare and life sciences that address unmet market needs, whether hardware, software, services or combinations. It targets innovations that improve patient treatment and care, generate actionable insights, or create efficiency gains across drug development and the patient journey. The firm's approach is grounded in macro trends such as an aging global population, the burden of chronic disease, and rising healthcare costs that make data and value-based care essential. It invests in companies demonstrating feasibility to bring disruptive innovation to market, at seed, Series A and Series B stages, tailoring investments for efficient value creation. It also provides mentorship, hands-on support and operational expertise, aiming to combine financial returns with societal impact.
Source: firm website, verified Aug 3, 2026.
Team · 13 people
from the firm's website & curated & public directories
What they invest in
from 14 of 18 portfolio companiesAI & Machine Learning ×11Biotech ×7Healthtech ×6Deep Tech ×5Medical Devices ×5Data & Infrastructure ×4Digital Health ×4Enterprise Software ×3
HQs:Belgium×5Spain×1Netherlands×1United States×1
Investments · 18 tracked
founders shown can be your intro pathBy year:2026 · 12025 · 12021 · 12014 · 14 dated
Amaron develops an Enterprise Application Integration platform that enables healthcare organizations to exchange data seamlessly between their systems and devices using Mirth Connect and open standards like HL7, FHIR, and DICOM.
Cloud ComputingData & InfrastructureDigital HealthEnterprise SoftwareHealthtechBelgium, BE
Tom De Caluwé(Founder)in
Aspect Analytics develops computational infrastructure for spatial biology analysis, enabling scientists to extract actionable insight from multimodal biological data to accelerate drug development.
AI & Machine LearningBiotechData & InfrastructureDeep TechSaaS
Co-investorsCapricorn Venture PartnersPMV
Broken String Biosciences develops tools for genome-wide on- and off-target analysis in gene editing, enabling in-house detection and characterization of gene editing-induced DNA breaks.
AI & Machine LearningBiotechDeep Tech
Co-investorsFirst In VenturesIllumina VenturesKorysMérieux Equity Partners
Fluidic Sciences develops in-solution technologies and instruments for protein interaction analysis, enabling researchers to measure how proteins interact without immobilization complexities.
AI & Machine LearningBiotechDeep TechHardware
James Wilkinson(Chief Executive Officer)in
BoardMark Gilligan(Chairman)
Co-investorsCambridge Innovation CapitalDraper Esprit
Gynaia provides training, certification, quality assessment, and clinical decision support tools for gynecological ultrasound professionals, including an LMS, curated clinical case database, live case webinars, and diagnostic apps such as the ADNEX model.
AI & Machine LearningDigital HealthEdTechFemTech
Hypervision Surgical develops an intraoperative hyperspectral imaging system that uses AI to provide real-time, contrast-free tissue characterisation during surgery.
AI & Machine LearningHealthtechMedical Devices
Co-investorsHeal CapitalLifeX VenturesMeridian Health VenturesSonorcapZEISS VenturesAngelini Ventures+2 more
Icometrix develops AI-powered medical imaging software for analyzing brain MRI scans to help clinicians diagnose and monitor neurological conditions like Alzheimer's disease, stroke, and traumatic brain injury.
AI & Machine LearningDigital HealthMedical DevicesLeuven, BE
Wim Van Hecke(Founder)in
Co-investorsCapricorn Venture PartnersForestay CapitalOptum Ventures
Scalable, high throughput DNA sequencing platforms.
Co-investorsARCH Venture PartnersArtis VenturesHemisphere Ventures LLCSPRINGROCK VENTURESVenrockGenesys Capital
ImmuneSpecs uses immunopeptidomics (MAPPs) technology to identify peptides presented by MHC molecules, enabling precise mapping of T cell epitopes in biotherapeutics and validation of immunotherapy targets.
BiotechDeep TechHealthtechMedical Devices
LynxCare enables hospitals and life sciences organizations to generate clinical insights from harmonized real-world health datasets.
AI & Machine LearningData & InfrastructureHealthtechBrussels, BE
Co-investorsimec.istartMatterwave VenturesElaiaFlare Capital Partners
Nuclivision develops AI software to enhance nuclear medicine imaging, enabling PET centers to increase capacity and reduce costs without replacing equipment.
AI & Machine LearningHealthtechMedical DevicesGhent, BE
Maarten Larmuseau(Cofounder & CEO)inTomas Brants(Cofounder & COO)inSimon DeKeyser(Cofounder & CTO)in
Co-investorsimec.istart
ONTOFORCE provides data science solutions and support services centered around DISQOVER, guiding customers through implementation, customization, and ongoing support to meet their specific needs.
AI & Machine LearningBiotechData & InfrastructureEnterprise Software
Co-investorsimec.istartKorys
Pharmacelera develops computational chemistry software and services for drug discovery, using proprietary 3D molecular field descriptors, quantum mechanics, and AI to screen ultra-large chemical libraries and identify novel, synthesizable compounds.
AI & Machine LearningBiotechDeep TechBarcelona, ES
Enric Gibert(Founder)inEnric Herrero(Founder)in
Co-investorsCapital CellGENERAL INCEPTION
Thermo Fisher provides life science products and laboratory equipment, including antibodies, consumables, biobanking resources, and Cryo-EM imaging systems for research labs and scientists.
BiotechEnterprise SoftwareHardwareHealthtechWaltham, US
Anthony Uzzo(Executive Officer, Director)inJoshua Geballe(Executive Officer, Director)James Gregory(Executive Officer, Director)Marc N. Casper(Executive Officer, Director)inAndrew J. Thomson(Executive Officer)Peter M. Wilver(Executive Officer)
Co-investorsARCH Venture PartnersBayMed Venture PartnersCross Creek AdvisorsEric F. ThiessenExcel Venture ManagementHighsage Ventures+6 more
Thirona develops AI software for lung disease diagnosis and treatment planning in hospitals.
AI & Machine LearningDigital HealthMedical Devicesundefined, NL
Eva van Rikxoort(Founder & CEO)in
Co-investorsBorski Fund
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
PharmaFluidicsUgenTecVixenbio
Portfolio news
latest coverage across their companiesPharmacelera · finsmes.com · Feb 18, 2026
Gynaia · gynaia.com · May 22, 2025
Frequently asked questions
- How many investments has Heran Partners made?
- Heran Partners has 18 tracked investments, 2 of which have exited, including 2 dated in the last 24 months.
- What stage does Heran Partners invest at?
- Heran Partners invests at the Seed, Series A, Series B stages.
- What sectors does Heran Partners focus on?
- Heran Partners focuses on Biotech, Digital Health, Healthtech, Impact & Social Good, Medical Devices.
- Where is Heran Partners located?
- Heran Partners is headquartered in Antwerp, BE.
- Who does Heran Partners co-invest with?
- Heran Partners most often shares deals with imec.istart, ARCH Venture Partners, Capricorn Venture Partners, among 28 tracked co-investors.
Images
Similar investors
Lerer Hippeau is an early-stage venture capital firm that backs founders across sectors, emphasizing investing in companies before they gain wider recognition.
Global Health Investment Corporation (GHIC) is a nonprofit that invests in life sciences and healthcare technology companies to accelerate the development and accessibility of products improving global public health and health equity.
Novo Holdings is the holding and investment company that manages the assets of the Novo Nordisk Foundation, serving as controlling shareholder of Novo Nordisk and Novonesis. It invests in life science companies across all stages and manages a diversified portfolio of equities, bonds, real estate, infrastructure and private equity.
Voima Ventures is a deep tech venture capital firm that backs founders building global solutions across people, planet, and industry, from technology spin-offs to scaling companies.
MDI Ventures is the corporate venture capital arm of Indonesian telecommunications company Telkom Indonesia, investing in high-growth technology startups across Southeast Asia and globally, with a focus on creating synergies between portfolio companies and Telkom Group and Indonesian state-owned enterprises.